Effects of the estrogen replacement therapy on different biochemical markers of endothelial reactivity in recent postmenopausal healthy women

Immuno-Analyse et Biologie Specialisee

Volumn 20, Issue 3, 2005, Pages 181-185

  Vassalle, Cristina ^a   Prontera, Concetta ^a   Zucchelli, Gian Carlo ^a   Maffei, Silvia ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Cardiovascular risk factors; Endothelial function; Hormone replacement therapy; Menopause; Vasoactive factors

Indexed keywords

BIOCHEMICAL MARKER; CATECHOLAMINE DERIVATIVE; ENDOTHELIN 1; ESTROGEN; NITRIC OXIDE; PROSTACYCLIN;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 20444407960     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immbio.2005.03.005     Document Type: Article

References (25)

1. N.K. Wenger Clinical characteristics of coronary heart disease in women: emphasis on gender differences Cardiovasc. Res. 53 2002 558 567
2. J.E. Rossouw Hormones, genetic factors, and gender differences in cardiovascular disease Cardiovasc. Res. 53 2002 550 557
3. T.S. Mikkola, and T.B. Clarkson Estrogen replacement therapy, atherosclerosis, and vascular function Cardiovasc. Res. 53 2002 605 719
4. L. Mosca, J.E. Manson, S.E. Sutherland, R.D. Langer, T. Manolio, and E. Barrett-Connor Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group Circul. 96 1997 2468 2482
5. F. Grodstein, M.J. Stampfer, J.E. Manson, G.A. Colditz, W.C. Willett, and B. Rosner Postmenopausal estrogen and progestin use and the risk of cardiovascular disease N. Engl. J. Med. 335 1996 453 461
6. The Women's Health Initiative Study Group Design of the Women's Health Initiative clinical trial and observational study Control. Clin. Trials 19 1998 61 109
7. K.K. Koh Can a healthy endothelium influence the cardiovascular effects of hormone replacement therapy? Int. J. Cardiol. 87 2003 1 8
8. M.R. Adams, J.R. Kaplan, S.B. Manuck, D.R. Koritnik, J.S. Parks, and M.S. Wolfe Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone Arteriosclerosis 10 1990 1051 1057
9. S. Oparil Hormones and vasoprotection Hypertension 33 1999 170 176
10. D.W. Losordo, M. Kearney, E.A. Kim, J. Jekanowski, and J.M. Isner Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women Circulation 89 1994 1501 1510
11. J. Loscalzo Endothelial injury, vasoconstriction, and its prevention Tex. Heart Inst. J. 22 1995 180 184
12. D.O. Ruehlmann, and G.E. Mann Actions of oestrogen on vascular endothelial and smooth-muscle cells Biochem. Soc. Trans. 25 1997 40 45
13. C. Vassalle, C. Prontera, A. Mercuri, G.C. Zucchelli, and S. Maffei Nitric oxide and catecholamines levels after estrogen replacement therapy: results of a cross-over study Proceedings of the European congress of clinical chemistry and laboratory medicine 2003 2003 Monduzzi 943 949
14. Maffei S, Mercuri A, Zucchelli GC, Vassalle C. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women. Int J Cardiol (in press).
15. H. Kawano, T. Motoyama, K. Kugiyama, O. Hirashima, M. Ohgushi, and H. Fujii Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation J. Am. Coll. Cardiol. 30 1997 914 919
16. P.J. Best, P.B. Berger, V.M. Miller, and A. Lerman The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women Ann. Intern. Med. 128 1998 285 288
17. PEPI Trial Writing Group Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial J. Am. Med. Assoc. 273 1995 199 208
18. B.W. Walsh, I. Schiff, B. Rosner, L. Greenberg, V. Ravnikar, and F.M. Sacks Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins N. Engl. J. Med. 325 1991 1196 1204
19. J.E. Muller, G.H. Tofler, and E. Edelman Probable triggers of onset of acute myocardial infarction Clin. Cardiol. 12 1989 473 475
20. G. Del Rio, A. Velardo, G. Zizzo, A. Avogaro, C. Cipolli, and L. Della Casa Effect of estradiol on the sympathoadrenal response to mental stress in normal men J. Clin. Endocrinol. Metab. 79 1994 836 840
21. B. Larsson, K.E. Andersson, S. Batra, A. Mattiasson, and C. Sjogren Effects of estradiol on norepinephrine-induced contraction, alpha adrenoceptor number and norepinephrine content in the female rabbit urethra J. Pharmacol. Exp. Ther. 229 1984 557 563
22. Z.Q. Ma, G.P. Bondiolotti, M. Olasmaa, E. Violani, C. Patrone, and G.B. Picotti Estrogen modulation of catecholamine synthesis and monoamine oxidase A activity in the human neuroblastoma cell line SK-ER3 J. Steroid Biochem. Mol. Biol. 47 1993 207 311
23. W.S. Colucci, M.A. Gimbrone Jr., M.K. McLaughlin, W. Halpern, and R.W. Alexander Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen-treated male rats Circ. Res. 50 1982 805 811
24. B. Klangkalya, and A. Chan The effects of ovarian hormones on beta-adrenergic and muscarinic receptors in rat heart Life Sci. 42 1988 2307 2314
25. L. Gandia, L.F. Casado, M.G. Lopez, and A.G. Garcia Separation of two pathways for calcium entry into chromaffin cells Br. J. Pharmacol. 103 1991 1073 1078